SARS-CoV-2 spike protein | CoronaCentral

SARS-CoV-2 spike protein [Gene or Protein]

Published and Preprint Papers

Topics & Article Type(s)

Title

Therapeutics, Vaccines [Research]

Engineered Nanovesicles Expressing Bispecific Single Chain Variable Fragments to Protect against SARS-CoV-2 Infection.

Vaccines [Research]

Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects.

Vaccines [Research]

Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial.

Vaccines [Research]

Engineering a dual vaccine against COVID-19 and tuberculosis.

Immunology, Vaccines [Research]

Vaccine-induced SARS-CoV-2 antibody response: the comparability of S1-specific binding assays depends on epitope and isotype discrimination.

Immunology, Molecular Biology [Research]

Immune targets to stop future SARS-CoV-2 variants.

Therapeutics [Review]

Nigella sativa and its chemical constituents: pre-clinical and clinical evidence for their potential anti-SARS-CoV-2 effects.

Therapeutics [Research]

Plant virus-derived nanoparticles decorated with genetically encoded SARS-CoV-2 nanobodies display enhanced neutralizing activity.

Therapeutics [Research]

Coffee as a dietary strategy to prevent SARS-CoV-2 infection.

Vaccines [Review]

Discovery and development of COVID-19 vaccine from laboratory to clinic.